Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse.
Standard
Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse. / Schäfer, Ingo; Najavits, Lisa M.
in: CURR OPIN PSYCHIATR, Jahrgang 20, Nr. 6, 6, 2007, S. 614-618.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse.
AU - Schäfer, Ingo
AU - Najavits, Lisa M
PY - 2007
Y1 - 2007
N2 - PURPOSE OF REVIEW: The aim of this article is to review the current literature on co-occuring posttraumatic stress disorder and substance-use disorder, with an emphasis on clinical aspects and emerging treatments. RECENT FINDINGS: In clinical populations (focusing on either disorder), about 25-50% have a lifetime dual diagnosis of posttraumatic stress disorder and substance-use disorder. Patients with both disorders have a more severe clinical profile than those with either disorder alone, lower functioning, poorer well being, and worse outcomes across a variety of measures. In recent years, several promising treatment programs have been developed specifically for co-occuring posttraumatic stress disorder and substance-use disorder, with one model having been established as effective thus far. SUMMARY: Comorbid posttraumatic stress disorder/substance-use disorder is a frequent diagnosis in clinical populations that severely affects course and outcome. Treatment approaches appropriate for this vulnerable population need to be evaluated further and implemented in routine practice.
AB - PURPOSE OF REVIEW: The aim of this article is to review the current literature on co-occuring posttraumatic stress disorder and substance-use disorder, with an emphasis on clinical aspects and emerging treatments. RECENT FINDINGS: In clinical populations (focusing on either disorder), about 25-50% have a lifetime dual diagnosis of posttraumatic stress disorder and substance-use disorder. Patients with both disorders have a more severe clinical profile than those with either disorder alone, lower functioning, poorer well being, and worse outcomes across a variety of measures. In recent years, several promising treatment programs have been developed specifically for co-occuring posttraumatic stress disorder and substance-use disorder, with one model having been established as effective thus far. SUMMARY: Comorbid posttraumatic stress disorder/substance-use disorder is a frequent diagnosis in clinical populations that severely affects course and outcome. Treatment approaches appropriate for this vulnerable population need to be evaluated further and implemented in routine practice.
M3 - SCORING: Zeitschriftenaufsatz
VL - 20
SP - 614
EP - 618
JO - CURR OPIN PSYCHIATR
JF - CURR OPIN PSYCHIATR
SN - 0951-7367
IS - 6
M1 - 6
ER -
